Skip to main content
. 2022 Jul 18;12:12269. doi: 10.1038/s41598-022-15791-6

Figure 1.

Figure 1

Percent inhibition of Spike-ACE2 binding in association with number of reported symptoms in seropositive individuals. Boxplot indicating mean, interquartile range, and outlier measurements of log10-corrected surrogate neutralization levels for seropositive participants who reported 0ā€“11 symptoms of COVID-19 infection21. Nā€‰=ā€‰790.